An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)
Gaughan et al., American Journal of Respiratory and Critical Care Medicine, doi:10.1164/rccm.202203-0477OC
https://c19early.org/gaughan.html